Concepedia
Statistics
Publications
24
Citations
1.7K
H-Index
16
Active since
1981
Affiliations
BC Cancer Agency(Current)
Vancouver General Hospital
Rush University Medical Center
Terry Fox Research Institute
University of British Columbia
Hans-G. Klingemann is an author at BC Cancer Agency specializing in hematology, medicine, and immunology.
Publications per year
1981–2012
Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Jiang-Hong Gong, Guitta Maki, Hans-G. Klingemann · PubMed · 1994 · 729 citations
Life Sciences, Cell Biology, Immunology +10
Factors Regulating the Cytotoxic Activity of the Human Natural Killer Cell Line, NK-92
Guitta Maki, Hans-G. Klingemann, Jeffrey Martinson et al. · Journal of Hematotherapy & Stem Cell Research · 2001 · 267 citations
Life Sciences, Cell Biology, Immunology +16
Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow Transplantation
Thomas J. Nevill, Henry C. Fung, John D. Shepherd et al. · Blood · 1998 · 161 citations
Medicine, Genetics, Hematology +14
Immunotherapy of Malignant Melanoma in a SCID Mouse Model Using the Highly Cytotoxic Natural Killer Cell Line NK-92
Ying K. Tam, Blythe Miyagawa, Vincent Ho et al. · Journal of Hematotherapy · 1999 · 129 citations
Life Sciences, Immunology, Oncology +13
Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Donna Reece, Michael J. Barnett, J M Connors et al. · PubMed · 1993 · 55 citations
Medicine, Hematology, Oncology +14
1–5 of 24